One of the most attended presentations at the ADA Scientific Sessions was a short talk by Mark Espeland, Ph.D. He was focusing on how weight reduction and physical activity can have a positive effect on cognitive function. When our Publisher, Steve Freed, caught up with him, he was surprised to …

Combination ANRI sacubitril/valsartan (EntrestoR) showed significant reduction in risk for cardiovascular death and hospitalization for worsening heart failure.

Study prompts more concerns for future seniors with diabetes.

Studies show that half of Chinese adults have an increased risk for prediabetes and diabetes; Tibetan and Muslim Chinese at lowest risk.

Dr. Mark Espeland, PhD is the founding chair of the Department of Biostatistical Sciences at Wake Forest School of Medicine in Winston-Salem, NC. In this interview, he discusses his presentation on lifestyle intervention in diabetes, the LOOK AHEAD study.

A 62-year-old man presents with type 2 diabetes, hypertension, and albuminuria. His seated BP is 162/104 mm Hg. What's an ideal blood pressure target for this patient? A. 140/90 mm Hg B. 130/80 mm Hg C. 120/70 mm Hg D. 150/80 mm Hg Follow the link to see the right answer.

Through a partnership with Glooko, a leading diabetes data management platform, Novo Nordisk has launched a new mobile app – Cornerstones4Care (C4C) – which will help people more effectively track and manage their diabetes day-to-day.

At what A1c level would you recommend the use of metformin? 1. 5.6% 2. 5.7 – 5.9% 3. 6.0% 4. 6.1 – 6.2% 5. 6.3 – 6.4% 6. 6.5 – 7% Follow the link to share your response.

In this Exclusive Interview, Dr. Espeland discusses the LOOK AHEAD study and its findings, including the impact of lifestyle interventions on healthcare costs, and why exercise and weight loss can reduce cognitive decline, but also increase risk of hypoglycemia.

Dr. Mark Espeland discusses the background of the LOOK AHEAD study, which examines the effects of lifestyle interventions on adults with diabetes.